IQPC’s 4th Annual Biobanking Conference aims to address the major challenges faced by both start-up and established biorepositories. Leaders from various biobanks will address topics ranging from the discovery of drug targets to improving patient outcomes including:
•Mitigating risks associated with storing biospecimens
•Extracting value from sample repositories through biomarker research
•Expanding the reach of biocollections virtually
•Achieving operational excellence to assure quality expectations are met
Mark Mense, Head of Global Pathology, will provide a general overview of biobanking with a specific focus on the future of the biobanking industry.
Added by MedImmune on January 13, 2011